EU suspends sale of contraceptive implant

August 5, 2017

The sale of a contraceptive implant has been suspended for three months across the European Union after an Irish regulator said it was temporarily withholding renewal of the device's commercial licence.

The National Standards Authority of Ireland said it needed more information before renewing the licence for the Essure contraceptive device, its French counterpart told AFP.

As a result, the device "can no longer be sold in France or Europe during the temporary suspension period," which runs to November, the French ANSM medical safety authority said.

Essure's manufacturers Bayer say the device is a "minimally invasive" permanent birth control procedure.

"We would like to reassure the women who use Essure as their form of contraception and their that the safety and efficacy of Essure continues to be supported by more than a decade of science and real world clinical experience," the company said in a statement.

ANSM urged women to not use the Essure implant in the meantime "as a precaution".

Brazil's public health authority suspended the sale of the device in February pending further testing but lifted the ban last month.

Explore further: Women sue healthcare giant Bayer over contraceptive implants

Related Stories

Women sue healthcare giant Bayer over contraceptive implants

December 9, 2016
French lawyers for women who say a contraceptive implant sold by Bayer Healthcare had caused a string of medical complications launched a lawsuit against the multinational on Friday.

FDA to add bold warning to Essure contraceptive device

February 29, 2016
Federal health regulators plan to add new warnings to Essure, a much-debated contraceptive implant that has been subject to thousands of complaints from women reporting chronic pain, bleeding and other problems.

FDA petitioned to stop sales of essure implant

May 5, 2015
(HealthDay)—Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market, says a citizen's petition filed with the U.S. Food and Drug Administration.

Brazil lifts ban on controversial sterilization implants

July 11, 2017
Brazil has lifted a ban on the sale of Essure female sterilization implants after receiving results from clinical trials on its risks, authorities said Tuesday.

FDA aims to publish Essure safety review in February

November 24, 2015
Federal health officials aim to release their findings on a much-debated contraceptive implant by the end of February.

FDA reviewing safety of Essure birth control implant

June 25, 2015
Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

Recommended for you

Womb natural killer cell discovery could lead to screening for miscarriage risk

December 14, 2017
For the first time the functions of natural killer cells in the womb have been identified.

Hormone discovery marks breakthough in understanding fertility

December 12, 2017
Scientists at The University of Nottingham have shown, for the first time, that a naturally occurring hormone plays a vital part in regulating a woman's fertility, a discovery that could lead to better diagnosis and treatment ...

Study reveals Viagra to be 'ineffective' for fetal growth restriction

December 8, 2017
A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.

Obese first-time mums more likely to have premature babies

December 4, 2017
Obese women are up to three times more likely to have a premature child during their first pregnancy, according to a study from University College Dublin.

Stillbirth is not just stillbirth—more information is needed

December 4, 2017
Forty two babies are stillborn in Australia every week, and 60 per cent of them are recorded as "unexplained".

First baby from a uterus transplant in the US born in Dallas

December 2, 2017
The first birth as a result of a womb transplant in the United States has occurred in Texas, a milestone for the U.S. but one achieved several years ago in Sweden.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.